Virtu KCG Holdings’s Jazz Pharmaceuticals JAZZ Stock Holding History

Virtu KCG Holdings’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$1.98M	Buy	12,751 +6,847	+116%	+$1.05M	0.06%	255
2017 Q1	$857K	Sell	5,904 -789	-12%	-$103K	0.02%	840
2016 Q4	$730K	Buy	6,693 +4,685	+233%	+$522K	0.02%	1068
2016 Q3	$244K	Sell	2,008 -10,430	-84%	-$1.41M	0.01%	2156
2016 Q2	$1.76M	Buy	12,438 +9,686	+352%	+$1.43M	0.04%	408
2016 Q1	$359K	Sell	2,752 -2,009	-42%	-$250K	0.01%	1521
2015 Q4	$669K	Sell	4,761 -4,123	-46%	-$571K	0.01%	1230
2015 Q3	$1.18M	Buy	8,884 +4,720	+113%	+$813K	0.02%	751
2015 Q2	$733K	Sell	4,164 -4,288	-51%	-$770K	0.01%	1140
2015 Q1	$1.46M	Buy	8,452 +6,866	+433%	+$1.18M	0.03%	533
2014 Q4	$260K	Sell	1,586 -2,394	-60%	-$397K	﹤0.01%	2536
2014 Q3	$639K	Buy	+3,980	New	+$612K	0.01%	1418
2014 Q2	–	Sell	-8,771	Closed	-$1.22M	–	3865
2014 Q1	$1.22M	Buy	8,771 +3,828	+77%	+$576K	0.02%	1076
2013 Q4	$626K	Sell	4,943 -102	-2%	-$10.6K	0.01%	1693
2013 Q3	$464K	Buy	+5,045	New	+$407K	0.01%	2095

Other funds holding JAZZ

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Virtu KCG Holdings's JAZZ Position: Q2 2017 in Review

Virtu KCG Holdings increased its Jazz Pharmaceuticals (JAZZ) stake by 116% in Q2 2017, buying an estimated $1.05M and bringing the position to 12,751 shares worth $1.98M. The position accounts for 0.06% of the portfolio, ranked #255.

Virtu KCG Holdings first reported a position in JAZZ in Q3 2013 and has held it in 15 quarters since. 319 funds tracked by Wall St. Rank hold JAZZ as of Q2 2017.

Virtu KCG Holdings held 12,751 shares of Jazz Pharmaceuticals worth $1.98M as of Q2 2017.
Virtu KCG Holdings bought 6,847 Jazz Pharmaceuticals shares in Q2 2017, an estimated $1.05M.
Jazz Pharmaceuticals made up 0.06% of Virtu KCG Holdings's portfolio in Q2 2017, its #255 holding.
Virtu KCG Holdings first reported a position in Jazz Pharmaceuticals in Q3 2013 and has held it in 15 quarters since.
319 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.